I-Mab Full Year 2023 Earnings: Revenues Beat Expectations, EPS Lags [Yahoo! Finance]
I-MAB - American Depositary Shares (IMAB)
Company Research
Source: Yahoo! Finance
CN¥16.53 loss per share (improved from CN¥29.23 loss in FY 2022). All figures shown in the chart above are for the trailing 12 month (TTM) period I-Mab Revenues Beat Expectations, EPS Falls Short Revenue exceeded analyst estimates by 43%. Earnings per share (EPS) missed analyst estimates by 32%. In the last 12 months, the only revenue segment was Biotechnology contributing CN¥27.6m. The largest operating expense was Research & Development (R&D) costs, amounting to CN¥810.6m (54% of total expenses). Explore how IMAB's revenue and expenses shape its earnings. Looking ahead, revenue is forecast to grow 56% p.a. on average during the next 3 years, compared to a 18% growth forecast for the Biotechs industry in the US. Performance of the American Biotechs industry. The company's shares are up 2.8% from a week ago. Risk Analysis Be aware that I-Mab is showing 3 warning signs in our investment analysis that you should know about... Have feedback on this article? Concerned
Show less
Read more
Impact Snapshot
Event Time:
IMAB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMAB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMAB alerts
High impacting I-MAB - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
IMAB
News
- I-Mab (NASDAQ: IMAB) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $6.00 price target on the stock.MarketBeat
- I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare Conference [Yahoo! Finance]Yahoo! Finance
- I-Mab to Participate at the 23rd Annual Needham Virtual Healthcare ConferencePR Newswire
- I-Mab Announces Closing of the Divestiture of Business Operations in China [Yahoo! Finance]Yahoo! Finance
- I-Mab Announces Closing of the Divestiture of Business Operations in ChinaPR Newswire
IMAB
Sec Filings
- 4/15/24 - Form 6-K
- 4/2/24 - Form 6-K
- 4/1/24 - Form 6-K
- IMAB's page on the SEC website